CRISPR gene editing can create cells immune to HIV
Could a better understanding of inflammation help research towards an HIV cure?
First trial results of new immune-modulating drugs presented in Mexico City
Beyond antibodies: conference hears of new molecular tools to kill HIV-infected reservoir cells
How can researchers reduce risks to sexual partners in studies involving treatment interruptions?
In unique case, Australian man appears to have cleared his HIV infection
Analytical treatment interruptions: minimising the risks and maximising their scientific value
Monoclonal antibody may lead to long-term viral load reduction
‘Gentler cure’ technique produces delay in viral rebound in some people taken off HIV therapy
